| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Business & Legal Officer
2 companies
Gregory S. Moss is Chief Business & Legal Officer at EVMN and has filed Form 4s across 2 companies. Gregory S. Moss's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $465K at current prices.
The biggest single holding is EVMN (~$361K) as Chief Business & Legal Officer. The EVMN filings lean toward selling, a net 14,223 shares.
Gregory S. Moss has 7 Form 4 filings on record from November 2025 to June 2026, across 2 companies: Director at Anteris Technologies Global (AVR), 2025–2026; Chief Business & Legal Officer at Evommune (EVMN), 2025–2026.
The 9 reported transactions were 4 option or other derivative awards, 2 option exercises, 1 open-market sale and 1 tax withholding, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $325K.
The only open-market sale was 14,223 shares of EVMN at an average $22.83 on May 28, 2026, about $325K.